Robert A Fenstermaker Selected Research

Robert A Fenstermaker Research Topics

Disease

28	Neoplasms (Cancer) 01/2021 - 06/2002
26	Glioma (Gliomas) 01/2021 - 06/2002
8	Brain Neoplasms (Brain Tumor) 12/2018 - 01/2004
7	Glioblastoma (Glioblastoma Multiforme) 02/2020 - 07/2006
2	Myasthenia Gravis 10/2020 - 01/2014
2	Endometrial Stromal Sarcoma 11/2011 - 02/2004
2	Meningioma (Meningiomas) 11/2011 - 02/2004
2	Lymphoma (Lymphomas) 08/2010 - 05/2007
2	Melanoma (Melanoma, Malignant) 08/2009 - 11/2008
1	Autoimmune Diseases (Autoimmune Disease) 10/2020
1	Experimental Melanoma 01/2018
1	Heart Arrest (Cardiac Arrest) 07/2016
1	Hyperkalemia 07/2016
1	Neuroepithelial Neoplasms (Gliomatosis Cerebri) 01/2016
1	Oligodendroglioma 09/2013
1	Adenosarcoma 11/2011
1	Sarcoma (Soft Tissue Sarcoma) 11/2011
1	Neuroectodermal Tumors (Neuroectodermal Tumor) 11/2008
1	Neuroblastoma 11/2008
1	Carcinogenesis 05/2007
1	Breast Neoplasms (Breast Cancer) 11/2006
1	Hypothyroidism 07/2006

Drug/Important Bio-Agent (IBA)

9	SurvivinIBA 10/2020 - 12/2006
8	ErbB Receptors (EGF Receptor)IBA 02/2008 - 06/2002
7	Monoclonal AntibodiesIBA 01/2018 - 11/2004
7	VaccinesIBA 12/2017 - 02/2005
7	BoronIBA 12/2009 - 06/2002
6	Peptides (Polypeptides)IBA 10/2020 - 02/2005
6	Epidermal Growth Factor (EGF)IBA 12/2009 - 06/2002
6	epidermal growth factor receptor VIIIIBA 02/2008 - 01/2004
4	Proteins (Proteins, Gene)FDA Link 10/2020 - 12/2006
4	AntigensIBA 08/2010 - 02/2005
4	EpitopesIBA 08/2010 - 02/2005
4	Cetuximab (Erbitux)FDA Link 02/2008 - 01/2004
3	Protein Subunit VaccinesIBA 11/2016 - 12/2008
3	Cancer VaccinesIBA 08/2010 - 12/2006
3	Dendrimers (Dendrons)IBA 12/2009 - 11/2002
2	Pharmaceutical PreparationsIBA 01/2021 - 12/2018
2	Cholinergic ReceptorsIBA 10/2020 - 01/2014
2	Therapeutic UsesIBA 12/2018 - 12/2008
2	Inhibitor of Apoptosis ProteinsIBA 01/2018 - 12/2017
2	Temozolomide (Temodar)FDA LinkGeneric 01/2016 - 01/2015
2	Megestrol Acetate (Borea)FDA LinkGeneric 11/2011 - 02/2004
2	Progesterone Receptors (Progesterone Receptor)IBA 11/2011 - 02/2004
2	Progesterone FDA LinkGeneric 11/2011 - 02/2004
2	HLA-A*02:01 antigenIBA 08/2010 - 12/2008
2	Hormones (Hormone)IBA 11/2006 - 02/2004
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 11/2006 - 07/2006
2	Cell Surface ReceptorsIBA 11/2006 - 07/2006
2	Thyroid HormonesIBA 11/2006 - 07/2006
1	KX2-361IBA 12/2018
1	TubulinIBA 12/2018
1	Tubulin ModulatorsIBA 12/2018
1	AntibodiesIBA 01/2018
1	Tumor Biomarkers (Tumor Markers)IBA 12/2017
1	Glial Fibrillary Acidic ProteinIBA 12/2017
1	HLA-A Antigens (HLA-A)IBA 11/2016
1	Apoptosis Regulatory ProteinsIBA 11/2016
1	sargramostim (Leukine)FDA Link 11/2016
1	montanide ISA 51IBA 11/2016
1	Insulin (Novolin)FDA Link 07/2016
1	CalciumIBA 07/2016
1	Mannitol (Osmitrol)FDA LinkGeneric 07/2016
1	AutoantibodiesIBA 01/2014
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2014
1	LigandsIBA 08/2010
1	A 7 (A-7)IBA 12/2009
1	Proteoglycans (Proteoglycan)IBA 08/2009
1	CollagenIBA 11/2008
1	CarbohydratesIBA 11/2008
1	Activated-Leukocyte Cell Adhesion Molecule (Neurolin)IBA 11/2008
1	GD2 gangliosideIBA 11/2008
1	Peptide LibraryIBA 11/2008
1	Polysaccharides (Glycans)IBA 11/2008
1	Cell Adhesion MoleculesIBA 11/2008
1	Glycoproteins (Glycoprotein)IBA 11/2008
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 11/2008
1	VDJ RecombinasesIBA 05/2007
1	Hypoxanthine Phosphoribosyltransferase (Hypoxanthine Guanine Phosphoribosyltransferase)IBA 05/2007
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 05/2007
1	TransferasesIBA 05/2007
1	HypoxanthineIBA 05/2007
1	Thyroid Hormone Receptors (Thyroid Hormone Receptor)IBA 11/2006
1	IntegrinsIBA 11/2006
1	tetraiodothyroacetic acid (TA(4))IBA 11/2006
1	Integrin alphaVbeta3IBA 07/2006
1	Mitogen-Activated Protein KinasesIBA 07/2006
1	Mitogen-Activated Protein Kinase 3IBA 07/2006
1	Thyroxine (Levothyroxine)FDA LinkGeneric 07/2006

Therapy/Procedure

11	Therapeutics 12/2018 - 02/2004
6	Drug Therapy (Chemotherapy) 12/2017 - 05/2004
6	Boron Neutron Capture Therapy 12/2009 - 11/2002
6	Neutron Capture Therapy 12/2009 - 06/2002
3	Immunotherapy 12/2017 - 05/2004
3	Radiotherapy 01/2016 - 05/2004
2	Craniotomy 02/2020 - 07/2016
1	Investigational Therapies (Experimental Therapy) 12/2017
1	Subcutaneous Injections 11/2016
1	Nuclear Reactors 02/2008
1	Time-to-Treatment 03/2005